Search for members, bills, votes, committees, hearings, and nominations
The End Veterans Overdose Act of 2026 would direct the Department of Veterans Affairs to make opioid overdose rescue medications, such as naloxone, available free of charge at VA pharmacies to eligible veterans and their caregivers without requiring a prescription. Currently, VA pharmacies provide naloxone at no cost but require veterans to first obtain a prescription from a provider. This bill would remove that barrier to access.
The bill requires that anyone receiving these medications also receive information on how to use them properly. It includes privacy protections to ensure that personal information collected for medication purposes cannot be used against veterans for employment decisions or to label them as substance abusers. The legislation has been approved by the Senate Committee on Veterans' Affairs and is eligible for a floor vote. If enacted, the bill would likely expand access to these life-saving medications, particularly for caregivers, and is expected to help reduce overdose deaths among veterans, who face higher rates of opioid-related deaths than the general population.
AI-generated summary
Congress
119th Congress
Introduced
Feb 2, 2026
Committee on Veterans' Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
Mar 18, 2026
Mar 18, 2026 · 16:00
On March 18, 2026, the Senate Committee on Veterans' Affairs held a business meeting to consider a wide-ranging slate of legislation designed to improve the lives of veterans, their survivors, and their families. The meeting focused on more than 20 individual bills addressing critical gaps in current Department of Veterans Affairs (VA) services. Key proposals included S.342, which would allow Purple Heart recipients to transfer unused Post-9/11 GI Bill benefits to family members, and S.649, which seeks to expand education eligibility for National Guard members. Other significant measures, such as the Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act, aimed to fund research into the health conditions of children whose parents were exposed to toxic substances during military service. The committee also reviewed administrative and healthcare reforms, such as S.1657, which prevents the VA from denying benefit claims solely because a veteran missed a medical exam, and S.3138, which would provide specialized prosthetics for veterans participating in sports and recreation. Additional bills addressed rural healthcare access, emergency management capabilities, and the timely certification of death certificates by VA medical staff. By bundling these diverse issues into a single business meeting, the committee signaled an effort to streamline legislative improvements across the VA's educational, medical, and cemetery administrations. Because this was a business meeting to consider the legislation, the committee's primary goal was to discuss the merits of the bills and potentially vote on whether to report them to the full Senate for further consideration. While the meeting represents a significant step in the legislative process, it does not guarantee that any of the bills will become law. Each measure must still pass the full Senate and the House of Representatives before being sent to the President for a signature.
Committee on Veterans' Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
Mar 18, 2026
Mar 18, 2026 · 16:00
On March 18, 2026, the Senate Committee on Veterans' Affairs held a business meeting to consider a wide-ranging slate of legislation designed to improve the lives of veterans, their survivors, and their families. The meeting focused on more than 20 individual bills addressing critical gaps in current Department of Veterans Affairs (VA) services. Key proposals included S.342, which would allow Purple Heart recipients to transfer unused Post-9/11 GI Bill benefits to family members, and S.649, which seeks to expand education eligibility for National Guard members. Other significant measures, such as the Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act, aimed to fund research into the health conditions of children whose parents were exposed to toxic substances during military service. The committee also reviewed administrative and healthcare reforms, such as S.1657, which prevents the VA from denying benefit claims solely because a veteran missed a medical exam, and S.3138, which would provide specialized prosthetics for veterans participating in sports and recreation. Additional bills addressed rural healthcare access, emergency management capabilities, and the timely certification of death certificates by VA medical staff. By bundling these diverse issues into a single business meeting, the committee signaled an effort to streamline legislative improvements across the VA's educational, medical, and cemetery administrations. Because this was a business meeting to consider the legislation, the committee's primary goal was to discuss the merits of the bills and potentially vote on whether to report them to the full Senate for further consideration. While the meeting represents a significant step in the legislative process, it does not guarantee that any of the bills will become law. Each measure must still pass the full Senate and the House of Representatives before being sent to the President for a signature.
